KOPP INVESTMENT ADVISORS LLC - Q3 2016 holdings

$101 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 64 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 16.1% .

 Value Shares↓ Weighting
OCLR SellOclaro, Inc.$8,222,000
-84.8%
961,623
-91.3%
8.13%
-71.8%
FNSR SellFinisar Corp.$5,965,000
-47.2%
200,161
-69.0%
5.90%
-1.9%
TLGT SellTeligent, Inc.$5,176,000
-65.1%
681,030
-67.2%
5.12%
-35.1%
GIMO SellGigamon Inc.$4,917,000
-56.5%
89,719
-70.3%
4.86%
-19.2%
NEO SellNeoGenomics Inc$4,107,000
-65.4%
499,582
-66.2%
4.06%
-35.7%
XENT SellIntersect ENT Inc.$3,781,000
-54.7%
238,698
-63.0%
3.74%
-15.8%
OMCL SellOmnicell Inc.$3,637,000
-19.7%
94,957
-28.2%
3.60%
+49.2%
NXTM SellNxStage Medical, Inc$3,124,000
-11.5%
124,997
-23.2%
3.09%
+64.4%
ATRC BuyAtriCure Inc.$3,105,000
+17.3%
196,278
+4.8%
3.07%
+118.1%
AKRXQ BuyAkorn, Inc.$2,939,000
-0.5%
107,801
+3.9%
2.90%
+84.8%
IDTI BuyIntegrated Device Technology Inc.$2,815,000
+20.2%
121,846
+4.8%
2.78%
+123.5%
IL SellIntraLinks Holdings Inc.$2,712,000
+41.1%
269,585
-8.8%
2.68%
+162.2%
EGHT Sell8x8. Inc.$2,424,000
-2.3%
157,095
-7.4%
2.40%
+81.7%
LGND SellLigand Pharmaceuticals Inc$2,394,000
-34.0%
23,458
-22.9%
2.37%
+22.6%
RTIX SellRTI Surgical Inc.$2,265,000
-52.1%
723,743
-45.1%
2.24%
-11.0%
ARRY SellArray Biopharma Inc.$2,223,000
+73.3%
329,282
-8.6%
2.20%
+222.1%
SWKS SellSkyworks Solutions$2,164,000
+10.5%
28,420
-8.1%
2.14%
+105.5%
KTWO SellK2M Grp Hldgs$2,089,000
+2.5%
117,498
-10.6%
2.06%
+90.3%
CVLT SellCommVault Systems Inc.$2,072,000
+21.0%
38,993
-1.7%
2.05%
+124.8%
CALD SellCallidus Software$2,071,000
-16.3%
112,861
-8.9%
2.05%
+55.5%
PODD SellInsulet Corp.$2,047,000
+21.1%
50,007
-10.5%
2.02%
+125.0%
SPSC SellSPS Commerce, Inc.$1,893,000
+12.3%
25,789
-7.3%
1.87%
+108.6%
QRVO SellQorvo Inc.$1,879,000
-7.3%
33,703
-8.1%
1.86%
+72.3%
CEMP SellCempra, Inc$1,722,000
+0.9%
71,140
-31.3%
1.70%
+87.4%
MXL SellMaxLinear, Inc.cl a$1,322,000
+10.6%
65,224
-1.8%
1.31%
+105.5%
ENZ SellEnzo Biochem, Inc$1,181,000
-71.1%
232,099
-66.1%
1.17%
-46.3%
SUPN SellSupernus Pharmaceuticals, Inc.$1,158,000
+18.8%
46,839
-2.2%
1.14%
+120.4%
BMRN SellBioMarin Pharmaceutical Inc.$1,053,000
+15.7%
11,384
-2.7%
1.04%
+115.1%
MMM Sell3M Company$1,008,000
-13.8%
5,719
-14.3%
1.00%
+60.1%
SPY  SPDR Trust Ser 1tr unit$984,000
+3.3%
4,5500.0%0.97%
+91.9%
HSTM SellHealthStream, Inc.$932,000
+1.1%
33,771
-2.9%
0.92%
+88.0%
LUV SellSouthwest Airlines Co.$891,000
-17.3%
22,910
-16.7%
0.88%
+53.8%
EOG SellEOG Resources$845,000
-1.6%
8,735
-15.2%
0.84%
+82.7%
JNJ SellJohnson & Johnson$837,000
-18.0%
7,089
-15.8%
0.83%
+52.3%
CMI SellCummins Inc.$834,000
-3.0%
6,510
-14.8%
0.82%
+80.3%
MAR SellMarriott Intl. Inc.cl a$829,000
-16.7%
12,319
-17.7%
0.82%
+54.8%
AFL SellAflac Incorporated$818,000
-18.5%
11,384
-18.2%
0.81%
+51.3%
PG SellThe Procter & Gamble Company$808,000
-10.4%
9,002
-15.5%
0.80%
+66.5%
HRL SellHormel Foods Corporation$807,000
-11.4%
21,265
-14.6%
0.80%
+64.5%
QCOM SellQUALCOMM Inc.$793,000
+8.8%
11,582
-14.9%
0.78%
+102.1%
HAL SellHalliburton Company$779,000
-13.1%
17,360
-12.3%
0.77%
+61.4%
VZ SellVerizon Communications Inc.$751,000
-20.4%
14,446
-14.5%
0.74%
+47.8%
D SellDominion Res Inc. VA$708,000
-17.2%
9,535
-13.1%
0.70%
+53.8%
EMN SellEastman Chemical Co.$707,000
-13.9%
10,451
-13.5%
0.70%
+60.0%
VFC SellV F Corporation$703,000
-21.3%
12,537
-13.7%
0.70%
+46.3%
JPM NewJP Morgan Chase$644,0009,673
+100.0%
0.64%
XOM SellExxon Mobil Corporation$635,000
-21.4%
7,274
-15.6%
0.63%
+46.0%
TROW SellT. Rowe Price$628,000
-21.5%
9,438
-13.9%
0.62%
+45.8%
AXP SellAmerican Express Company$625,000
-8.9%
9,756
-13.6%
0.62%
+69.3%
JWN SellNordstrom Inc.$579,000
+22.7%
11,163
-9.9%
0.57%
+127.9%
VTI  Vanguard Total Stocktotal stk mkt$401,000
+3.9%
3,6000.0%0.40%
+93.2%
QQQ  PowerShares QQQ Trustunit ser 1$350,000
+10.4%
2,9500.0%0.35%
+104.7%
VCSH  Vanguard Short-Term Corporateshrt trm corp bd$322,000
-0.3%
4,0000.0%0.32%
+84.9%
HWAY SellHealthways Inc.$304,000
+46.9%
11,505
-35.7%
0.30%
+172.7%
EGRX NewEagle Pharmaceuticals, Inc.$302,0004,310
+100.0%
0.30%
CYNA NewCynapsus Therapeutics Inc.$296,0007,359
+100.0%
0.29%
GE  General Electric Co.$257,000
-5.9%
8,6600.0%0.25%
+75.2%
ENTL SellEntellus Medical, Inc$241,000
+12.1%
10,853
-7.9%
0.24%
+108.8%
GILD SellGilead Sciences Inc.$221,000
-7.5%
2,788
-2.8%
0.22%
+71.7%
TECH  Bio-Techne Corp.$219,000
-3.1%
2,0000.0%0.22%
+80.0%
AAPL NewApple Inc.$214,0001,890
+100.0%
0.21%
INTC NewIntel Corp.$208,0005,504
+100.0%
0.21%
LXRX SellLexicon Pharmaceuticals Inc.$207,000
+11.3%
11,435
-11.8%
0.20%
+107.1%
SCON NewSuperconductor Technologies, Inc.$38,00014,339
+100.0%
0.04%
VCYT ExitVeracyte Inc.$0-21,975
-100.0%
-0.06%
LDRH ExitLDR Holding Corporation$0-6,253
-100.0%
-0.12%
WFC ExitWells Fargo & Co.$0-19,298
-100.0%
-0.49%
SCON ExitSuperconductor Technologies, Inc.$0-7,907,791
-100.0%
-0.80%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NeoGenomics Inc.26Q3 20198.2%
RTI Surgical Inc.26Q3 20196.0%
Omnicell Inc.26Q3 20194.7%
AtriCure Inc.26Q3 20194.6%
Ligand Pharmaceuticals Inc.26Q3 20194.5%
SPDR Trust Ser 126Q3 20192.3%
Marriott Intl. Inc.26Q3 20191.5%
Southwest Airls Co.26Q3 20191.3%
3M Company26Q3 20191.2%
Aflac Incorporated26Q3 20191.1%

View KOPP INVESTMENT ADVISORS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
KOPP INVESTMENT ADVISORS LLC Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SUPERCONDUCTOR TECHNOLOGIES INCAugust 19, 2016528,96316.6%
EMCORE CORPApril 01, 20161,248,9704.8%
VITESSE SEMICONDUCTOR CORPMay 05, 2015? ?
TRANSGENOMIC INCMay 23, 201483,5021.1%
RTI SURGICAL, INC.January 03, 20141,984,6183.5%
SYNERGETICS USA INCJanuary 03, 2014877,2533.5%
MINDSPEED TECHNOLOGIES, INCDecember 13, 20132,068,4164.8%
TRANSGENOMIC INCNovember 01, 201313,744,08615.6%
OCLARO, INC.September 20, 20138,592,5179.3%
SUPERCONDUCTOR TECHNOLOGIES INCDecember 21, 20128,776,33517.4%

View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR/A2018-08-15
13F-HR2018-08-14
13F-HR2018-05-14
13F-HR2018-02-14
13F-HR2017-11-14

View KOPP INVESTMENT ADVISORS LLC's complete filings history.

Compare quarters

Export KOPP INVESTMENT ADVISORS LLC's holdings